Therefore, compared to CRP, EAT exhibits superior potential in predicting the occurrence of metabolic syndrome and other comorbidities in COPD patients, thereby facilitating an enhanced patient prognosis. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.